Trained immunity in viral infections, Alzheimer's disease and multiple sclerosis: A convergence in type I interferon signalling and IFNß-1a.
Biochim Biophys Acta Mol Basis Dis
; 1868(9): 166430, 2022 09 01.
Article
in English
| MEDLINE | ID: covidwho-1930739
ABSTRACT
Type I interferon (IFN-I) signalling represents a major target for modulation in a virus' bid for latency. IFN-I perturbations are also present in such as Alzheimer's disease (AD) and multiple sclerosis (MS), where viral infections are known to increase symptomatic burden. IFN-I modulation such as via IFNß-1a, an established MS treatment, has been researched to a limited extent to both AD and COVID-19. In this mini review, we present emerging research on trained immunity as a pathogenetic basis for Alzheimer's disease and the emerging context for IFNß-1a repositioning, via mechanisms shared with multiple sclerosis and induced by viral infections.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Virus Diseases
/
Alzheimer Disease
/
COVID-19
/
Multiple Sclerosis
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Biochim Biophys Acta Mol Basis Dis
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS